Actively Recruiting
Comprehensive Assessment in a Longitudinal Study on Young Men Who Have Sex With Men Attracting to chemseX-2
Led by Institute of HIV Research and Innovation Foundation, Thailand · Updated on 2026-04-02
150
Participants Needed
2
Research Sites
263 weeks
Total Duration
On this page
Sponsors
I
Institute of HIV Research and Innovation Foundation, Thailand
Lead Sponsor
T
The US NIH through the International Epidemiology Databases to Evaluate AIDS (IeDEA) IeDEA Asia-Pacific
Collaborating Sponsor
AI-Summary
What this Trial Is About
CLYMAX is a two-phase observational study that assess multiple aspects of chemsex and young men who have sex with men (YMSM). Phase I of the study (CLYMAX,IRB No. 0695/65) was a cross-sectional descriptive study using a mixed methods data collection (focusing on qualitative data collection) assessing multiple aspects of chemsex, including the patterns of chemsex use and the perspectives on factors influencing chemsex initiation/discontinuation, effects on physical health, mental health and social outcomes, and the necessary services for a comprehensive chemsex clinic among YMSM; and the acceptability and feasibility of developing a comprehensive chemsex clinic from the perspective of YMSM, their family members or peers, and clinic staff. This phase II study (CLYMAX-2) will be a prospective cohort study using a quantitative data collection exploring the effectiveness of the implementation strategy of harm reduction models and consist of a larger number of YMSM, important baseline and follow-up information on multiple aspects of physical, psychological, and social harms.
CONDITIONS
Official Title
Comprehensive Assessment in a Longitudinal Study on Young Men Who Have Sex With Men Attracting to chemseX-2
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men who have sex with men
- Aged 16-35 years
- Current chemsex users (last chemsex use within 3 months)
- Able to read and communicate in Thai
- Provide informed consent
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Rainbow Sky Association of Thailand (RSAT)
Bangkok, Bangkapi, Thailand, 10240
Actively Recruiting
2
Foundation for Action on Inclusion Rights (FAIR)
Bangkok, Minburi, Thailand, 10510
Actively Recruiting
Research Team
N
Nittaya Phanuphak, MD.,PhD
CONTACT
J
Jakkrapatara Boonruang, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here